Heron Therapeutics
HRTX
#8076
Rank
S$0.24 B
Marketcap
$1.63
Share price
-5.47%
Change (1 day)
117.81%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.60

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.57. In 2022 the company made an earnings per share (EPS) of -$2.33 an increase over its 2021 EPS that were of -$3.03.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.60-31.04%
2022-$2.33-23.11%
2021-$3.03-10%
2020-$3.36-0%
2019-$3.361.21%
2018-$3.32-32.7%
2017-$4.94-19.34%
2016-$6.1254.76%
2015-$3.961.73%
2014-$3.89-16.23%
2013-$4.6491.67%
2012-$2.42-31.45%
2011-$3.53-27.06%
2010-$4.84-43.75%
2009-$8.61-57.33%
2008-$20.18-82.92%
2007-$118.1220.61%
2006-$97.94175.76%
2005-$35.52-21.43%
2004-$45.20100%
2003-$22.60-38.24%
2002-$36.59161.54%
2001-$13.99-106.46%
2000$216.452051.55%
1999$10.06839.73%
1998$1.07-105.48%
1997-$19.55-88.16%
1996-$165.12

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.75-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.19-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.19 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.11-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.22 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA